Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

890
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

590
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

757
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
757
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

375
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
375
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of the PREVENT Score with coronary artery and thoracic aortic calcification among South Asian Americans.

American journal of preventive cardiology·2026
Same author

Associations of county-level school expenditure around time of birth and cardiovascular health in young adulthood.

American journal of preventive cardiology·2026
Same author

Trends in pre-pregnancy diabetes and gestational diabetes by U.S. State, 2016-2024.

American journal of preventive cardiology·2026
Same author

Systematic examination of the PREVENT equations for cardiovascular disease risk.

American journal of preventive cardiology·2026
Same author

Trends in cardiovascular mortality among disaggregated Asian American subgroups: 2018-2022.

American journal of preventive cardiology·2026
Same author

Factors Influencing the Uptake of Digital Health Interventions for Cardiovascular Disease Prevention Among Healthcare Providers: A Systematic Review.

Global heart·2026

Related Experiment Video

Updated: Jan 17, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

Trends in Mortality Rates for Cardiovascular Disease Subtypes Among Adults, 2010-2023.

Rebecca C Woodruff1, Xin Tong1, Adam S Vaughan1

  • 1Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Chamblee, Georgia.

American Journal of Preventive Medicine
|September 21, 2025
PubMed
Summary
This summary is machine-generated.

Cardiovascular disease mortality rates declined for ischemic heart disease and cardiomyopathy but rose for hypertensive disease, arrhythmia, and pulmonary heart disease between 2010 and 2023. These trends highlight the need for targeted prevention strategies for specific cardiovascular disease subtypes.

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.4K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.8K

Related Experiment Videos

Last Updated: Jan 17, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.4K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.8K

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiology

Background:

  • Cardiovascular disease (CVD) mortality rates, declining pre-pandemic, rose in 2020-2022.
  • Understanding trends by CVD subtype is crucial for effective prevention and management.

Purpose of the Study:

  • To analyze temporal trends in mortality rates for 8 major cardiovascular disease subtypes in U.S. adults from 2010 to 2023.
  • To identify specific CVD subtypes with increasing or decreasing mortality burdens.

Main Methods:

  • Calculated annual age-standardized mortality rates using National Vital Statistics System data (2010-2023).
  • Classified deaths into 8 major CVD subtypes.
  • Evaluated temporal trends using average annual percentage change.

Main Results:

  • In 2023, highest rates were for ischemic heart disease (117.9/100,000) and hypertensive disease (111.2/100,000).
  • Significant declines observed in ischemic heart disease (-2.21%/year) and cardiomyopathy (-3.00%/year).
  • Significant increases noted in hypertensive disease (2.52%/year), arrhythmia (1.14%/year), and pulmonary heart disease (1.38%/year).

Conclusions:

  • Mortality rates for ischemic heart disease and cardiomyopathy improved from 2010-2023.
  • Mortality rates worsened for hypertensive disease, arrhythmia, and pulmonary heart disease.
  • Findings necessitate focused prevention and clinical management for growing CVD subtype burdens.